Ascendis Pharma
ASND
ASND
102 hedge funds and large institutions have $2.63B invested in Ascendis Pharma in 2018 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 30 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
5% more capital invested
Capital invested by funds: $2.49B → $2.63B (+$136M)
3.48% more ownership
Funds ownership: 91.83% → 95.31% (+3.5%)
14% less funds holding in top 10
Funds holding in top 10: 14 → 12 (-2)
Holders
102
Holding in Top 10
12
Calls
$32.5M
Puts
$5.92M
Top Buyers
| 1 | +$69.6M | |
| 2 | +$30M | |
| 3 | +$28.2M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$18.7M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14.5M |
Top Sellers
| 1 | -$25.6M | |
| 2 | -$23.8M | |
| 3 | -$23.3M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$15.5M |
| 5 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$13.6M |